A Study of LY3127804 in Participants With COVID-19

Stopped early · Phase 2 · Has a placebo group

Conditions studied: COVID-19, Pneumonia

In brief

A randomized, double-blind, placebo-controlled, clinical trial of LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.

Key facts

Study ID
NCT04342897
Run by
Eli Lilly and Company
People needed
95
Starts
2020-04-20
Expected to finish
2020-10-12
Last updated by the study team
2021-08-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.